Contingency Fees In Franck’s Compounded Drug MDL Capped At 28 Percent By Judge

(September 14, 2015, 11:05 AM EDT) -- NEW ORLEANS — A Louisiana federal judge overseeing a $2.6 million compounded drug injury settlement on Sept. 10 limited plaintiff attorney contingency fees to 28 percent plus reasonable costs (In Re: Franck’s Lab, Inc., Products Liability Litigation, MDL Docket No. 2454, E.D. Pa.).

(Franck’s fee order available. Document #28-150917-002R.)

Frank’s Lab Inc. is a compounding pharmacy that made Brilliant Blue G, an injectable drug used during eye surgery. Plaintiffs allege that the drug was contaminated with fungus, resulting in eye fungal infections, eye damage and, in...
To view the full article, register now.